Internet Gaming Disorder — Collective Motivational Interviewing (CMI) for Adolescents With Internet Gaming Disorder
Citation(s)
Chou, K L. (2000). Assessing Chinese adolescents' social support: The multidimensional scale of perceived social support. Personality and Individual Differences, 28(2), 299-307. https://doi.org/bpjrkw
Qin L, Cheng L, Hu M, Liu Q, Tong J, Hao W, Luo T, Liao Y Clarification of the Cut-off Score for Nine-Item Internet Gaming Disorder Scale-Short Form (IGDS9-SF) in a Chinese Context. Front Psychiatry. 2020 May 25;11:470. doi: 10.3389/fpsyt.2020.00470. eCollection 2020.
Rustin TA, Tate JC Measuring the stages of change in cigarette smokers. J Subst Abuse Treat. 1993 Mar-Apr;10(2):209-20. doi: 10.1016/0740-5472(93)90046-5.
Ryan RM, Deci EL Intrinsic and Extrinsic Motivations: Classic Definitions and New Directions. Contemp Educ Psychol. 2000 Jan;25(1):54-67. doi: 10.1006/ceps.1999.1020.
Savci, M , & Griffiths, M. D. (2019). The development of the Turkish craving for internet gaming scale (CIGS): A validation study. International Journal of Mental Health and Addiction, 1-18.
Siu AMH, Ko FSL, Mak SK Outcome Evaluation of a Short-Term Hospitalization and Community Support Program for People Who Abuse Ketamine. Front Psychiatry. 2018 Jul 17;9:313. doi: 10.3389/fpsyt.2018.00313. eCollection 2018. Erratum In: Front Psychiatry. 2019 Jan 22;9:746.
Zhu S, Zhuang Y, Lee P, Li JC, Wong PWC Leisure and Problem Gaming Behaviors Among Children and Adolescents During School Closures Caused by COVID-19 in Hong Kong: Quantitative Cross-sectional Survey Study. JMIR Serious Games. 2021 May 7;9(2):e26808. doi: 10.2196/26808.
A Randomized Controlled Study of Collective Motivational Interviewing (CMI) for Adolescents With Internet Gaming Disorder
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
